Opko Health

OPKO Health, Inc. is a multi-national pharmaceutical and diagnostics company that aims to establish industry-leading positions in large and rapidly growing medical markets by leveraging our discovery, development, and commercialization expertise and our novel and proprietary technologies. We intend to leverage our global commercialization expertise to pursue acquisitions of commercial businesses that will both drive our growth and provide geographically diverse sales and distribution opportunities. We have and may continue to make investments in other early stage companies that we perceive to have valuable proprietary technology and significant potential to create value for OPKO as a shareholder. Our Focus is on Point-of-Care and Novel Molecular Diagnostics, Proprietary Pharmaceuticals, and Vaccines. Since 2009, OPKO has completed five national and international acquisitions contributing to its technology and commercial operations. OPKO continues to explore acquisition opportunities for complementary pharmaceuticals, compounds, technologies, and businesses. We expect our future growth to arise from leveraging our proprietary technology, development strengths, and pursuit of complementary and strategic acquisitions and investments.
Type
Public
HQ
Miami, US
Founded
2007
Size (employees)
6,041 (est)+2%
Website
opko.com
Opko Health was founded in 2007 and is headquartered in Miami, US

Key People at Opko Health

Phillip Frost

Phillip Frost

CEO
Jane H. Hsiao

Jane H. Hsiao

CTO

Opko Health Office Locations

Opko Health has offices in Miami, Woburn
Miami, US (HQ)
4400 Biscayne Blvd

Opko Health Metrics

Opko Health Financial Metrics

Revenue (2016)

$1.2 b

Revenue growth (2015-16), %

148%

Net income (2016)

($25.1 m)

Market capitalization (21-Mar-2017)

$4.5 b

Closing share price (21-Mar-2017)

$8

Cash (31-Dec-2016)

$168.7 m
Opko Health's current market capitalization is $4.5 b.
Opko Health's revenue was reported to be $1.2 b in FY, 2016 which is a 148.4% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$96.5 m$91.1 m$491.7 m$1.2 b

Revenue growth, %

(6%)440%148%

Gross profit

$47.7 m$43.1 m$449.8 m

Gross profit Margin, %

49%47%91%

Operating expense total

$176.2 m$236.9 m$590.2 m$1.3 b

EBIT

($79.6 m)($145.8 m)($98.5 m)($73.3 m)

EBIT margin, %

(82%)(160%)(20%)(6%)

Interest expense

$13.8 m$12.3 m$8.4 m$7.4 m

Interest income

$376 k$771 k$255 k$478 k

Income tax expense

($1.7 m)($24 k)$113.7 m$56.1 m

Net Income

($117.3 m)($174.6 m)($31.4 m)($25.1 m)
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$185.8 m$193.6 m$168.7 m

Accounts Receivable

$19.8 m$193.9 m$220.3 m

Inventories

$19.1 m$26.9 m

Current Assets

$242.7 m$454.1 m$483.6 m

PP&E

$131.8 m$122.8 m

Goodwill

$226.4 m$743.3 m$704.6 m

Total Assets

$1.4 b$2.8 b$2.8 b

Accounts Payable

$13.4 m$72.5 m$53.4 m

Current Liabilities

$91.9 m$251.9 m$263.3 m

Non-Current Liabilities

$426.7 m$567.9 m$411.5 m

Total Liabilities

$518.5 m$819.8 m$674.8 m

Preferred Stock

Additional Paid-in Capital

$1.4 b$2.7 b$2.8 b

Retained Earnings

($503.2 m)($704.9 m)($730 m)

Total Equity

$873 m$2 b$2.1 b

Financial Leverage

1.6 x1.4 x1.3 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

($117.3 m)($174.6 m)($31.4 m)($25.1 m)

Depreciation and Amortization

$11.1 m$14.9 m$28 m$64.4 m

Accounts Receivable

$19.8 m($3.9 m)($29 m)($26 m)

Inventories

$19.1 m$3.2 m($4.4 m)

Accounts Payable

$13.4 m($3.9 m)($18.1 m)($19.8 m)

Cash From Operating Activities

$158.4 m($90.4 m)$164 m$32 m

Capital Expenditures

($4.7 m)($10.8 m)($18.5 m)

Cash From Investing Activities

($5.7 m)($99.2 m)($20.7 m)

Cash From Financing Activities

$7.3 m$33 m($35.2 m)

Interest Paid

$6.3 m$4.6 m$2.9 m

Free Cash Flow

($85.6 m)$174.9 m$50.6 m

Opko Health Market Value History

Opko Health Online Presence

Opko Health News

Opko Health Company Life

You may also be interested in